| prasugrel / Generic mfg. |
| Ongoing | 2 | 20 | Europe | Definity, Powder for solution for infusion, Definity | VU Medical Center, Philips Medical System | Myocardial infarction, Myocardial infarction, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
2009-011907-22: Antiplatelet treatment in patients with diabetes mellitus: is there a difference between aspirin, clopidogrel and prasugrel |
|
|
| Ongoing | 2 | 56 | Europe | prasugrel hydrochloride, clopidogrel, aspirin, LY640315, Efient, plavix, Efient, plavix | University of Leeds | Type 2 diabetes mellitus | | | | |
2010-023945-31: Effect of Prasugrel sull\'iperreattivita\' bronchial and markers of airway inflammation in patients with chronic asthma: randomized crossover pilot study (Study PRINA). Effetto del Prasugrel sull\'iperreattivita\' bronchiale e sui marker di infiammazione delle vie aeree in pazienti con asma cronico: studio pilota randomizzato cross-over (Studio PRINA). |
|
|
| Ongoing | 2 | 26 | Europe | EFIENT, EFIENT | AZIENDA OSPEDALIERA S. PAOLO (A.O. DI RILIEVO NAZIONALE) | bronchial asthma asma bronchiale | | | | |
2020-003437-38: Optical Coherence Tomography-Guided PCI with Single-Antiplatelet Therapy |
|
|
| Ongoing | 2 | 1 | Europe | Film-coated tablet, Tablet, Prasugrel, Acetylsalicylic acid | AMC Medical Research B.V., Amsterdam UMC - location AMC | non-ST segment elevation acute coronary syndrome, non-ST segment elevation acute coronary syndrome, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
2020-005098-29: OPTI-STEMI is a randomized, non-profit, open label, multicentre phase II trial for the evaluation of new therapeutic strategies to reduce microvascular obstruction and to optimize revascularization in non-culprit stenosis in STEMI myocardial infarction. OPTI-STEMI è uno studio randomizzato, no-profit, open label, multicentrico di fase II per la valutazione di nuove strategie terapeutiche per ridurre l’ostruzione microvascolare e per ottimizzare la rivascolarizzazione in stenosi non-culprit nell’infarto miocardico STEMI. |
|
|
| Ongoing | 2 | 520 | Europe | Metoprololo, Atorvastatina, Eparina sodica, Adenosina, Colchicina, Clopidogrel, Ticagrelor, Liraglutide, Prasugrel, Ramipril, Acido acetilsalicilico, Abciximab, [NA], Infusion, Tablet, Solution for injection | DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA - UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II, Ministero dell’Istruzione, dell’Università e della Ricerca Progetto MIUR codice 2017PZY5K7 | Patients with acute ST-elevation myocardial infarction (STEMI) and multivessel coronary artery disease (MVD) defined by at least one non-culprit stenosis (NCS) with angiographic severity between 30 and 90% Pazienti infarto miocardico acuto con sopraslivellamento del tratto ST (STEMI) e con malattia coronarica multivasale (MVD) definita da almeno una stenosi non culprit (NCS) con severità angiografica tra il 30 ed il 90%, Patients with microvascular obstruction with non-culprit stenosis, i.e. with partial stenosis, between 30% and 90%, of coronary vessels. Pazienti con ostruzione microvascolare con stenosi non-culprit, ossia con stenosi parziale, tra il 30% e il 90%, dei vasi coronarici., Diseases [C] - Cardiovascular Diseases [C14] | | | | |
SYNIVUS-DAPT, NCT03606642: SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance and Dual Anti-Platelet Therapy |
|
|
| Active, not recruiting | 2 | 50 | US | Dual Antiplatelet (DAPT) Therapy, Ticagrelor (Brilinta), Clopidogrel (Plavix), Prasugrel (Effient) with Aspirin, The Synergy® stent | HonorHealth Research Institute, Boston Scientific Corporation | Coronary Artery Disease, Atherosclerosis, Stent Placement | 12/21 | 12/23 | | |
| Completed | 2 | 75 | Europe | Prasugrel 10mg, Ticagrelor 90mg | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Non ST Segment Elevation Acute Coronary Syndrome | 09/22 | 03/23 | | |
| Recruiting | 2 | 120 | US | Polypill, Usual Care (individual medications prescribed by primary cardiologist) | University of Texas Southwestern Medical Center | Acute Coronary Syndrome, Lipid Disorder, Coronary Artery Disease | 09/24 | 12/24 | | |
| Recruiting | 2 | 200 | Europe | Clopidogrel | St. Antonius Hospital | Acute Coronary Syndrome, CYP2C19 Polymorphism | 06/24 | 01/25 | | |
